ZNTL:Zentalis Pharmaceuticals Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$10.79 NASDAQ 4:05p ET
April 2 '24 		Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exert... GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Zentalis Pharmaceuticals to Highlight Preclinical Data Demonstrating that WEE1 Inhibitor Azenosertib Exerts Synergistic Anti-tumor Activity with KRAS(G12C) Inhibitors at AACR Annual Meeting 2024
     GlobeNewswire
    Full Story →

    Headline News
    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    5:30p ET April 1 '24 GlobeNewswire
    Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    6:00p ET March 1 '24 GlobeNewswire
    Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
    7:00a ET February 28 '24 GlobeNewswire
    More News →
    Day  8.33%Week  13.96%Month  23.42%More Charting →
    Today, 2:40p ET Thursday April 25 '24. Markets Open.
    Last $10.79
    Day change   8.33%$0.98
    Open $11.18
    Gap at open $0.59
    Previous close $11.77
    Trading volume 644,472
    10 Day avg vol. 697,584
    Shares out. 71.0Mil
    Market cap. $765.7Mil
    Trading activity Above Avg.
    Previous data from yesterday, April 24 '24.

    Historical Price Performance
    3 month   14.91% 
    6 month   33.40% 
    1 year   49.65% 
    2 year   50.60% 

    Earnings
    Previous 12m -$4.56
    Next 12m Estimate -$3.66
    P/E ratio 2.4x
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2024 All rights reserved.